Sponsorizzato
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
Posted
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Cerca
Categorie
- National
- International
- Business
- Technology
- Health
- Formazione
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Leggi tutto
House Republicans launch an all-nighter to try to pass Trump's big bill
House Republicans, led by Speaker Mike Johnson, are pushing forward with President Trump's...
India U-19 tour of England: Mhatre to lead, Sooryavanshi named in squad
Ayush Mhatre, a 17-year-old Mumbai opener, has been appointed as the captain of the India U-19...
Aditya Birla Fashion and Retail demerger: Why does it seem that ABFRL shares plunged 67%? Here’s what’s happened
Aditya Birla Fashion and Retail (ABFRL) shares plummeted by 67% following the demerger of its...
Byas Municipality declared fully vaccinated
TANAHU: Byas Municipality in Tanahun has been officially declared a fully vaccinated municipality...